Bodyport Receives FDA Clearance for the Bodyport Cardiac Scale
SAN FRANCISCO — August 9, 2022 — Bodyport, a digital therapeutics company on a mission to address complex chronic conditions, announced today that its noninvasive biomarker platform, the Bodyport Cardiac Scale™ received…